TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial.

Rebecca A Dent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.